The latest announcement is out from Universe Pharmaceuticals ( (UPC) ).
On March 20, 2025, Universe Pharmaceuticals INC announced a share consolidation plan, converting every 40 ordinary shares into one share with a new par value of US$11.25. This consolidation, effective March 24, 2025, aims to streamline the company’s share structure, impacting its trading on the Nasdaq Capital Market under the symbol ‘UPC’ with a new CUSIP number.
More about Universe Pharmaceuticals
Universe Pharmaceuticals INC, based in Ji’an, Jiangxi, China, is a pharmaceutical company focused on producing and distributing traditional Chinese medicine derivatives aimed at improving the well-being of the elderly. The company also deals in biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements, distributing its products across 30 provinces in China.
YTD Price Performance: -84.69%
Average Trading Volume: 12,569,876
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $830.6K
See more data about UPC stock on TipRanks’ Stock Analysis page.